2013年成人癫痫患者长程管理的专家共识

2014-01-08 佚名 dxy

癫痫是最常见而严重的神经系统疾病之一,已被世界卫生组织列入全球重点防治的五大神经精神疾病。流行病学调查显示,在我国癫痫患病率高达7% , 我国现有900 万以上癫痫患者,而且还以每年新发40 万- 60 万例的速度递增。癫痫致残率高,治愈困难,患者多需终生服药,疗程长。但临床上大多数癫痫患者治疗依从性差,擅自停药、减药、换药及拒服的比例高达679奋,直接导致癫痫控制不住,给患者家庭和社会带来沉重负



癫痫是最常见而严重的神经系统疾病之一,已被世界卫生组织列入全球重点防治的五大神经精神疾病。流行病学调查显示,在我国癫痫患病率高达7% , 我国现有900 万以上癫痫患者,而且还以每年新发40 万- 60 万例的速度递增。

癫痫致残率高,治愈困难,患者多需终生服药,疗程长。但临床上大多数癫痫患者治疗依从性差,擅自停药、减药、换药及拒服的比例高达679奋,直接导致癫痫控制不住,给患者家庭和社会带来沉重负担。因此癫痫的药物治疗迫切需要长期规范化管理。鉴于此,我们讨论并提出成人癫痫长程管理的专家共识,以指导临床对癫痫患者更合理、规范化的长程治疗及随访。
癫痫长程管理介绍

● 癫痫长程管理的理念

把管理(management)的理念引入癫痫全程治疗过程中。以患者为中心,关注患者整个治疗过程,在控制癫痫发作的同时,尽可能减少药物不良反应,使患者达到最好的治疗效果,以保持身心健康。在癫痫治疗开始制订方案的时候,就应该充分考虑到该疾病以及治疗过程可能对患者的长期影响。

● 癫痫长程管理的目标

(1)建立良好的医患关系,提高患者的依从性,提倡规范治疗,使癫痫发作得以长期控制;

(2)在治疗过程中,尽可能减少或避免药物使用的不良反应,包括近期及远期不良反应,提高患者的药物保留率;

(3)治疗相关共患病;

(4)提高患者生活质量,保持心理健康,使其重返社会。

● 癫痫长程管理的策略

使患者本人及家属参与治疗的决策,充分考虑患者的要求,制订长期良好的治疗随访计划;遵循抗癫痫药物(AEDs)治疗策略的个体化原则,根据癫痫临床发作类型、癫痫综合征、合并用的药物、共病及不同年龄段癫痫患者的生理特点及生活需求等,合理选择AEDs;在控制癫痫发作的同时,尽可能提高患者生活质量,并对患者的心理状态、学习、就业以及婚育等进行专业指导。



版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1844424, encodeId=0758184442425, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Sun Nov 09 18:20:00 CST 2014, time=2014-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2009192, encodeId=06d020091928c, content=<a href='/topic/show?id=1a35e15712e' target=_blank style='color:#2F92EE;'>#癫痫患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71571, encryptionId=1a35e15712e, topicName=癫痫患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Mar 24 05:20:00 CST 2014, time=2014-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10453, encodeId=39561045316, content=请问流行病学资料原始出处在哪儿呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8fd100240, createdName=RGB, createdTime=Sun Jul 13 16:41:00 CST 2014, time=2014-07-13, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1844424, encodeId=0758184442425, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Sun Nov 09 18:20:00 CST 2014, time=2014-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2009192, encodeId=06d020091928c, content=<a href='/topic/show?id=1a35e15712e' target=_blank style='color:#2F92EE;'>#癫痫患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71571, encryptionId=1a35e15712e, topicName=癫痫患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Mar 24 05:20:00 CST 2014, time=2014-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10453, encodeId=39561045316, content=请问流行病学资料原始出处在哪儿呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8fd100240, createdName=RGB, createdTime=Sun Jul 13 16:41:00 CST 2014, time=2014-07-13, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1844424, encodeId=0758184442425, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Sun Nov 09 18:20:00 CST 2014, time=2014-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2009192, encodeId=06d020091928c, content=<a href='/topic/show?id=1a35e15712e' target=_blank style='color:#2F92EE;'>#癫痫患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71571, encryptionId=1a35e15712e, topicName=癫痫患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Mar 24 05:20:00 CST 2014, time=2014-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10453, encodeId=39561045316, content=请问流行病学资料原始出处在哪儿呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8fd100240, createdName=RGB, createdTime=Sun Jul 13 16:41:00 CST 2014, time=2014-07-13, status=1, ipAttribution=)]
    2014-07-13 RGB

    请问流行病学资料原始出处在哪儿呢?

    0